Volume 16, Issue 5 – May-July 2017 - ACNR | Paper & Online Neurology Journal ACNR | Paper & Online Neurology Journal

This website is intended for healthcare professionals

Volume 16, Issue 5 – May-July 2017

Published on 13th Jun 2017

Advances in Clinical Neuroscience & Rehabilitation (Online) ISSN 2397-267X

Download this Issue

Articles in this issue

Lessons from Running a Neurology Strategic Clinical Network
Posted in Special Feature
18th Sep 2017
Nick Losseff

The Neuro Network Programme
Posted in Special Feature
18th Sep 2017
Julie Riley

Transcranial magnetic and electric stimulation of the cerebellum – A potential aid in enhancing rehabilitation of cerebral functions
Posted in Clinical Review Article
18th Sep 2017
Kim van Dun, Florian Bodranghien, Peter Marien, Mario Manto

Naming the Cranial Nerves: a historical note
Posted in History,Special Feature
18th Sep 2017
JMS Pearce

Book Review
Posted in Book Reviews
18th Sep 2017
Review by Rhys Davies: Evolution of the Cerebellar Sense of Self

Posted in Industry News,Rehabilitation Articles,Special Feature
20th Jul 2017
ACNR recently partnered with Mediaplanet UK on the 2017 Rehabilitation Campaign in The Guardian newspaper and online

The Missing Pieces: Identifying the gaps in care and conversations in MS
Posted in Online First,Special Feature,Sponsored Feature
10th Jul 2017
Developed and funded by Sanofi Genzyme

Visual testing in concussion
Posted in Australia/New Zealand,Clinical Review Article
9th Jul 2017
Clare L Fraser, Adrian Cohen

Roche’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary progressive multiple sclerosis
Posted in Industry News
3rd Jul 2017
News from Roche at the EAN congress

Data Provide Insight into the Mode of Action of MAVENCLAD™ (Cladribine Tablets) in Patients with Relapsing MS
Posted in Industry News
3rd Jul 2017
News from Merck at the EAN congress

Highlights from the EAN in Amsterdam
Posted in Courses & Conferences
29th Jun 2017
Read about the highlights from the recent European Academy of Neurology congress in Amsterdam

Zebinix® (eslicarbazepine acetate) Data Demonstrate No Significant Negative Consequences on Neurocognitive Function in Children with Focal Epilepsy
Posted in Industry News
28th Jun 2017
News on Zebinix in children with focal epilepsy from the EPNS

New Marketing Authorisation for Zebinix®
Posted in Industry News
6th Jun 2017
Press release on behalf of Bial and Eisai

Fatigue in multiple sclerosis: Why is it so difficult to manage?
Posted in Clinical Review Article
19th May 2017
Iulia Monica Bogdan, Mara Cercignani, Waqar Rashid

PREVIEW: The 3rd EAN Congress
Posted in Courses & Conferences
16th May 2017
Preview of the EAN meeting in Amsterdam, June 2017

PREVIEW: RehabWeek – fostering cross-disciplinary communication
Posted in Courses & Conferences
16th May 2017
Find out more about RehabWeek 2017 in London

PREVIEW: Neurology Academy launches first Palliative Care MasterClass
Posted in Courses & Conferences
16th May 2017
Preview of the new Palliative Care Masterclass from the Neurology Academy

PREVIEW: Brain Injury Rehabilitation Trust Conference
Posted in Courses & Conferences
16th May 2017
Preview of the Brain Injury Rehabilitation Trust Conference

PREVIEW: The 10th Practical Cognition Course
Posted in Courses & Conferences
16th May 2017
Preview of the Practical Cognition Course in Liverpool

The UCL Institute of Neurology Stroke Advanced Neuroimaging day
Posted in Courses & Conferences
16th May 2017
Review of UCL Stroke Imaging Day

A Dahl-icious evening: fireside with Professor Tom Solomon
Posted in Courses & Conferences
16th May 2017
Review of 'An Unexpected Evening with Roald Dahl’s Doctor'

Posted in Courses & Conferences
9th May 2017
Meeting preview - gain an insight into all the hot topics in TBI

PREVIEW: Advancing Epilepsy: ILAE British Chapter Annual Scientific Meeting
Posted in Courses & Conferences
8th May 2017
Preview of the 2017 ILAE British Chapter Annual Scientific Meeting

Path Finder – Visual Cues to Alleviate Freezing of Gait in Parkinson’s Disease
Posted in Special Feature
8th May 2017
Lise Pape, Kalyn Green and Ernest Lim

Tecfidera® and Tysabri® data show improved outcomes in early MS treatment
Posted in Neurology News
28th Apr 2017
Real-World Data Further Support Efficacy of Dimethyl Fumarate in Newly Diagnosed and Early Switch Patients MS Patients with High Disease Activity Benefit from Early...

Ready-to-use Epistatus® 10 mg Oromucosal Solution Midazolam – Marketing Authorisation granted
Posted in Neurology News
28th Apr 2017
27th April 2017: Special Products Ltd has announced that Epistatus® 10 mg Oromucosal Solution, Midazolam, has been granted a UK Marketing Authorisation for use in...

Study confirms Apomorphine subcutaneous infusion’s established role in PD
Posted in Neurology News
27th Apr 2017
Results from the first randomised, controlled trial investigating the efficacy and safety of APO-go®/MOVAPO® (apomorphine) subcutaneous infusion in Parkinson’s disease (PD) patients whose motor...

11th Cambridge Dementia Course
Posted in Courses & Conferences
9th Apr 2017
Report by Oliver Cousins